Pralsetinib Products | Cleanchem - Pralsetinib is a tyrosine kinase inhibitor used to treat cancers with RET gene alterations, such as non-small cell lung cancer (NSCLC) and thyroid cancer. It works by blocking the abnormal RET protein, which is responsible for the growth and spread of cancer cells. Pralsetinib has shown promising results in treating RET-driven cancers and is used when other treatments have failed.

Cat. No: CL-PRS-02

CAS No: NA

Mol. F: C2413C3H32FN715N2O2

Mol. Wt: 538.6

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-03

CAS No: NA

Mol. F: C2613CH29D3FN9O2

Mol. Wt: 537.6

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-04

CAS No: 2778223-51-9

Mol. F: C18H25N5O3

Mol. Wt: 359.4

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-05

CAS No: 2097133-17-8

Mol. F: C10H11FN4 : HCl

Mol. Wt: 206.2 : 36.5

Inv. Status: Custom Synthesis

Cat. No: CL-PRS-06

CAS No: 2778223-52-0

Mol. F: C17H23N5O3

Mol. Wt: 345.4

Inv. Status: Custom Synthesis